ALLMedicine™ Arteriovenous Malformations Center

Aug 3rd, 2021 - Capillary malformation-arteriovenous malformation (CM-AVM) is a rare condition characterized by multiple cutaneous capillary malformations with potential associated arteriovenous malformations. RAS p21 protein activator 1 (RASA1) and ephrin type-B...

Aug 3rd, 2021 - Brain arteriovenous malformations (bAVMs) are unusual vascular pathologies characterized by the abnormal aggregation of dilated arteries and veins in the brain parenchyma and for which the absence of a normal vascular structure and capillary bed l...

Aug 2nd, 2021 - Pediatric brain arteriovenous malformations (AVMs) are a significant cause of morbidity but the role of multimodal therapy in the treatment of these lesions is not well understood. To compare the outcomes of stereotactic radiosurgery (SRS) with an...

Jul 31st, 2021 - Cerebral arteriovenous malformations (AVMs) are rare cerebral vascular lesions that are associated with high morbidity and mortality from hemorrhage; however, stereotactic radiosurgery (SRS) is a well-validated treatment modality. Few reports have...

Jul 26th, 2021 - Our purpose was to determine whether the coverage of brain parenchyma within the 12 Gy radiosurgical volume (V12) correlates with the development of radiation-induced changes (RICs) in patients with unruptured cerebral arteriovenous malformations ...

Jun 26th, 2009 - HHT is an autosomal dominant disease with an estimated prevalence of at least 1/5000 which can frequently be complicated by the presence of clinically significant arteriovenous malformations in the brain, lung, gastrointestinal tract and liver. HH...

Apr 17th, 2020 - A new endovascular route for the treatment of brain AVMs may be possible in some cases: Trans-Venous Embolization (TVE). The technique uses microcatheters to navigate to the draining veins of AVM, to reach and then fill the AVM nidus retrogradely ...

Mar 13th, 2020 - Purpose: Have an evaluation of clinical benefits and risks of hybrid operating techniques in management of cerebral arteriovenous malformations(AVMs). Meanwhile, as a new cooperative interventional modality, optimized workflows, technical key knot...

Feb 25th, 2020 - The cerebral arteriovenous malformations correspond to the formation of an entanglement of morphologically abnormal vessels called nidus, which shunt the blood circulation directly from the arterial circulation to the venous circulation. The cereb...

Dec 19th, 2019 - The recognized manifestations of HHT are all due to abnormalities of vascular structure. Epistaxis and digestive arteriovenous malformations may be responsible for severe hemorrhages in 5% of HHT patients, requiring repeated blood transfusions and...

Dec 4th, 2019 - This is an European multi-center observational study. Treatments and follow-up visits will be done as per standard of care. The objective of this study is to evaluate the efficacy and safety of the PHIL® device in the treatment of intracranial dur...

Jun 11th, 2021 - The Skill Checkup series provides a quick, case-style interactive quiz highlighting key guidelines- and evidence-based information to inform clinical practice. A 76-year-old man presented with syncope preceded by prolonged dizziness. His medical h...

Sep 10th, 2020 - NEW YORK (Reuters Health) - New guidelines provide updated advice on managing epistaxis and vascular malformations and new recommendations for managing gastrointestinal (GI) bleeding, anemia, pediatric care, and pregnancy and delivery. The expert ...

Apr 8th, 2019 - Angiotensin II antagonists may help prevent GI bleeding among heart failure patients with continuous-flow left ventricular assist devices (LVADs), a retrospective study suggested. Taking ACE inhibitors or angiotensin receptor blockers (ARBs) at an...

Dec 6th, 2018 - Two companies now owned by Medtronic have agreed to pay a total of $31 million to resolve US Department of Justice (DOJ) charges involving marketing violations and kickback schemes. Medical device maker ev3 has agreed to plead guilty to charges re...

Dec 6th, 2018 - Two companies now owned by Medtronic have agreed to pay a total of $31 million to resolve US Department of Justice (DOJ) charges involving marketing violations and kickback schemes. Medical device maker ev3 has agreed to plead guilty to charges re...